missing translation for 'onlineSavingsMsg'
Learn More
Learn More
R&D Systems™ Recombinant Mouse IL-27 p28/IL-30 Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
355.00€
Specifications
| Gene ID (Entrez) | 246779 |
|---|---|
| Molecular Weight (g/mol) | Observed Molecular Wt: 25-35kDa, reducing conditions, Predicted Molecular Wt.: 24.9kDa |
| Name | IL-27 p28/IL-30 |
| Quantity | 10 μg |
| Source | Mouse myeloma cell line,NS0-derived mouse IL-27 p28/IL-30 protein Phe29-Ser234,with a C-terminal 10-His tag |
| Product Code | Brand | Formulation | Price | Quantity & Availability | |||||
|---|---|---|---|---|---|---|---|---|---|
| Product Code | Brand | Formulation | Price | Quantity & Availability | |||||
|
18166400
|
R&D Systems™
7430-ML-010/CF |
Lyophilized from a 0.2μm filtered solution in HEPES, NaCl and CHAPS. |
355.00€
10µg |
Estimated Shipment: 30-01-2025
Log in to see stock. |
|||||
|
18327747
|
R&D Systems™
7430-ML-010 |
Lyophilized from a 0.2μm filtered solution in HEPES, NaCl and CHAPS with BSA as a carrier protein. |
355.00€
10µg |
Estimated Shipment: 30-01-2025
Log in to see stock. |
|||||
Description
The Recombinant Mouse IL-27 p28/IL-30 Protein is derived from NS0. The Recombinant Mouse IL-27 p28/IL-30 Protein has been validated for the following applications: Bioactivity.Specifications
| 246779 | |
| IL-27 p28/IL-30 | |
| Mouse myeloma cell line,NS0-derived mouse IL-27 p28/IL-30 protein Phe29-Ser234,with a C-terminal 10-His tag | |
| Unconjugated | |
| 90%, by SDS-PAGE under reducing conditions and visualized by silver stain. |
| Observed Molecular Wt: 25-35kDa, reducing conditions, Predicted Molecular Wt.: 24.9kDa | |
| 10 μg | |
| Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution. | |
| Recombinant |
Spot an opportunity for improvement?Share a Content Correction
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title